236 related articles for article (PubMed ID: 27748760)
1. Glutamine activates STAT3 to control cancer cell proliferation independently of glutamine metabolism.
Cacace A; Sboarina M; Vazeille T; Sonveaux P
Oncogene; 2017 Apr; 36(15):2074-2084. PubMed ID: 27748760
[TBL] [Abstract][Full Text] [Related]
2. Lactate promotes glutamine uptake and metabolism in oxidative cancer cells.
Pérez-Escuredo J; Dadhich RK; Dhup S; Cacace A; Van Hée VF; De Saedeleer CJ; Sboarina M; Rodriguez F; Fontenille MJ; Brisson L; Porporato PE; Sonveaux P
Cell Cycle; 2016; 15(1):72-83. PubMed ID: 26636483
[TBL] [Abstract][Full Text] [Related]
3. Glutamine affects T24 bladder cancer cell proliferation by activating STAT3 through ROS and glutaminolysis.
Sun N; Liang Y; Chen Y; Wang L; Li D; Liang Z; Sun L; Wang Y; Niu H
Int J Mol Med; 2019 Dec; 44(6):2189-2200. PubMed ID: 31661119
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC.
Liu W; Le A; Hancock C; Lane AN; Dang CV; Fan TW; Phang JM
Proc Natl Acad Sci U S A; 2012 Jun; 109(23):8983-8. PubMed ID: 22615405
[TBL] [Abstract][Full Text] [Related]
5. Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.
Grinde MT; Hilmarsdottir B; Tunset HM; Henriksen IM; Kim J; Haugen MH; Rye MB; Mælandsmo GM; Moestue SA
Breast Cancer Res; 2019 May; 21(1):61. PubMed ID: 31088535
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between ER and HER2 regulates c-MYC-mediated glutamine metabolism in aromatase inhibitor resistant breast cancer cells.
Chen Z; Wang Y; Warden C; Chen S
J Steroid Biochem Mol Biol; 2015 May; 149():118-27. PubMed ID: 25683269
[TBL] [Abstract][Full Text] [Related]
7. Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway.
Balanis N; Wendt MK; Schiemann BJ; Wang Z; Schiemann WP; Carlin CR
J Biol Chem; 2013 Jun; 288(25):17954-67. PubMed ID: 23653350
[TBL] [Abstract][Full Text] [Related]
8. STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells.
Pawlus MR; Wang L; Hu CJ
Oncogene; 2014 Mar; 33(13):1670-9. PubMed ID: 23604114
[TBL] [Abstract][Full Text] [Related]
9. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX
Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417
[TBL] [Abstract][Full Text] [Related]
10. Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch.
Lee SY; Jeon HM; Ju MK; Jeong EK; Kim CH; Park HG; Han SI; Kang HS
Oncotarget; 2016 Feb; 7(7):7925-39. PubMed ID: 26771232
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line.
Bjorge JD; Pang AS; Funnell M; Chen KY; Diaz R; Magliocco AM; Fujita DJ
PLoS One; 2011 Apr; 6(4):e19309. PubMed ID: 21541295
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
[TBL] [Abstract][Full Text] [Related]
13. MYC-induced cancer cell energy metabolism and therapeutic opportunities.
Dang CV; Le A; Gao P
Clin Cancer Res; 2009 Nov; 15(21):6479-83. PubMed ID: 19861459
[TBL] [Abstract][Full Text] [Related]
14. Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells.
Shin DS; Kim HN; Shin KD; Yoon YJ; Kim SJ; Han DC; Kwon BM
Cancer Res; 2009 Jan; 69(1):193-202. PubMed ID: 19118003
[TBL] [Abstract][Full Text] [Related]
15. Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells.
Yuan J; Yang Y; Gao Z; Wang Z; Ji W; Song W; Zhang F; Niu R
Breast Cancer Res Treat; 2017 Jul; 164(2):327-340. PubMed ID: 28470457
[TBL] [Abstract][Full Text] [Related]
16. Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells.
Lee J; Hahm ER; Singh SV
Carcinogenesis; 2010 Nov; 31(11):1991-8. PubMed ID: 20724373
[TBL] [Abstract][Full Text] [Related]
17. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction.
Wise DR; DeBerardinis RJ; Mancuso A; Sayed N; Zhang XY; Pfeiffer HK; Nissim I; Daikhin E; Yudkoff M; McMahon SB; Thompson CB
Proc Natl Acad Sci U S A; 2008 Dec; 105(48):18782-7. PubMed ID: 19033189
[TBL] [Abstract][Full Text] [Related]
18. MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer.
Shajahan-Haq AN; Cook KL; Schwartz-Roberts JL; Eltayeb AE; Demas DM; Warri AM; Facey CO; Hilakivi-Clarke LA; Clarke R
Mol Cancer; 2014 Oct; 13():239. PubMed ID: 25339305
[TBL] [Abstract][Full Text] [Related]
19. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
Yao A; Xiang Y; Si YR; Fan LJ; Li JP; Li H; Guo W; He HX; Liang XJ; Tan Y; Bao LY; Liao XH
J Cell Biochem; 2019 Apr; 120(4):6542-6554. PubMed ID: 30368881
[TBL] [Abstract][Full Text] [Related]
20. Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.
Nam K; Son SH; Oh S; Jeon D; Kim H; Noh DY; Kim S; Shin I
Oncotarget; 2017 May; 8(22):35804-35823. PubMed ID: 28415760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]